Satellite Symposia
Medtronic Satellite Symposium
INNOVATION IN HYPERTENSION: RENAL DENERVATION FOR THE TREATMENT FOR RESISTANT HYPERTENSION
Chairpersons: J. Redon (Valencia, Spain), R.E. Schmieder (Erlangen, Germany)
Welcome and Introduction
J. Redon (Valencia, Spain)
[WEBCAST]
SESSION 1 - Hypertension, sympathetic nervous system and renal denervation
Hypertension epidemiology and current treatment challenges
K. Narkiewicz (Gdansk, Poland)
[WEBCAST]
Resistant hypertension and the role of the sympathetic nervous system
R.E. Schmieder (Erlangen, Germany)
[WEBCAST]
Renal Denervation (RDN) procedure overview
J. Weil (Lubeck, Germany)
[WEBCAST]
SESSION 2 - Clinical trial results, evidence and future directions
Autonomic nervous system assessment: pathophysiology and pre-clinical/clinical trial data
M. Esler (Melbourne, Australia)
[WEBCAST]
RDN clinical trials overview
S.E. Kjeldsen (Oslo, Norway)
[WEBCAST]
RDN future trials (HTN-3, HF, global registry)
M.P. Schlaich (Melbourne, Australia)
[WEBCAST]
SESSION 3 - Renal Denervation in clinical practice and special situations
Renal Denervation in clinical practice
S.E. Kjeldsen (Oslo, Norway)
[WEBCAST]
Position papers
R.E. Schmieder (Erlangen, Germany)
[WEBCAST]
Patient selection
M. Lobo (London, United Kingdom)
[WEBCAST]
Post-operative patient management
M. Voskuil (London, United Kingdom)
[WEBCAST]
RDN resources and closing remarks
R.E. Schmieder (Erlangen, Germany)
[WEBCAST]
Thanks to 
